Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II randomized double-blind safety and efficacy trial.

Rigas, James R; Schuster, Michael W; Orlov, Sergey V; Milovanovic, Branislav M; Prabhash, Kumar; Smith, Jeffrey T

Results

eNauka > Results > Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II randomized double-blind safety and efficacy trial.

Title:	Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II randomized double-blind safety and efficacy trial.
Authors:	Rigas, James R; Schuster, Michael W; Orlov, Sergey V; Milovanovic, Branislav M; Prabhash, Kumar; Smith, Jeffrey T
Issue Date:	2010
Publication:	JOURNAL OF CLINICAL ONCOLOGY
ISSN:	0732-183X Journal of Clinical Oncology Search Idenfier
Type:	Conference Paper
Collation:	vol. 28 br. 15
WoS-ID:	000208852005002
URI:	https://enauka.gov.rs/handle/123456789/801173
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM